Sinopharm: its subsidiary obtained overseas registration certificate for API

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Alibaba's Qwen to Power Apple Intelligence in China, Bringing a Chinese Foundation Model into Apple's AI Ecosystem

Alibaba Group (阿里巴巴)'s large language model Qwen (通义千问) will provide core AI capabilities for Apple Intelligence in mainland China, following regulatory approval for Apple's AI services in the country.

China’s AI-Linked Computing Trade Reaches CNY 5.13 Trillion as June Exports Surge

China’s exports rose 27% year on year in U.S.-dollar terms in June, the fastest pace in four months, as global demand for artificial intelligence-related hardware provided a fresh source of support for the country’s export sector.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.